(AFX UK Focus) 2010-03-24 09:02 UPDATE 1-Vernalis dives as pain drug fails clinical test
LONDON, March 24 (Reuters) – An experimental drug for diabetes-related neuropathic pain from Vernalis failed to show benefits in a clinical trial, sending shares in the British biotech group plunging on Wednesday. Vernalis said it did not plan to conduct further studies with the medicine, known as V3381, for the condition, although an ongoing pilot trial with the product in chronic cough will be …
Read more on Interactive Investor
